141 related articles for article (PubMed ID: 35872619)
21. Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study.
Paul S; Zahurak M; Luznik L; Ambinder RF; Fuchs EJ; Bolaños-Meade J; Wagner-Johnston N; Swinnen LJ; Schoch L; Varadhan R; Jones RJ; Gladstone DE
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1679-1688. PubMed ID: 32592857
[TBL] [Abstract][Full Text] [Related]
22. High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
Andersson A; Enblad G; Erlanson M; Johansson AS; Molin D; Tavelin B; Näslund U; Melin B
Ups J Med Sci; 2021; 126():. PubMed ID: 33889307
[TBL] [Abstract][Full Text] [Related]
23. Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study.
Evens AM; Yu KS; Liu N; Surinach A; Holmes K; Flores C; Fanale MA; Flora DR; Parsons SK
Future Oncol; 2024 Apr; 20(12):749-760. PubMed ID: 37665273
[TBL] [Abstract][Full Text] [Related]
24. Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials.
Bröckelmann PJ; Goergen H; Kohnhorst C; von Tresckow B; Moccia A; Markova J; Meissner J; Kerkhoff A; Ludwig WD; Fuchs M; Borchmann P; Engert A
J Clin Oncol; 2017 May; 35(13):1444-1450. PubMed ID: 28240973
[TBL] [Abstract][Full Text] [Related]
25. Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.
Boddicker NJ; Larson MC; Castellino A; Herrmann J; Inwards DJ; Thanarajasingam G; Maurer MJ; Allmer C; Witzig TE; Nowakowski GS; Habermann TM; Villarraga HR; Slager SL; Cerhan JR; Thompson CA
Am J Hematol; 2021 Aug; 96(8):979-988. PubMed ID: 33971040
[TBL] [Abstract][Full Text] [Related]
26. Unfavorable early-stage Hodgkin lymphoma: assessment of patient characteristics in a real-world setting.
Gautam S; Yeola S; Nahar A; Sarpong EM; Prescott J; Yang X; Sineshaw HM
Future Oncol; 2023 Jun; 19(18):1249-1259. PubMed ID: 37293737
[TBL] [Abstract][Full Text] [Related]
27. Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006).
Eloranta S; Lambert PC; Sjöberg J; Andersson TM; Björkholm M; Dickman PW
J Clin Oncol; 2013 Apr; 31(11):1435-41. PubMed ID: 23439756
[TBL] [Abstract][Full Text] [Related]
28. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
30. Long-term risks of cardiovascular death in a population-based cohort of 1,141,675 older patients with cancer.
Guan T; Jiang Y; Luo Z; Liang Y; Feng M; Lu Z; Yi M; Teng Y; Zhou R; Zeng L; Chi K; Ou C; Chen M
Age Ageing; 2023 May; 52(5):. PubMed ID: 37192506
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: An Australian population-based study.
Ye Y; Otahal P; Marwick TH; Wills KE; Neil AL; Venn AJ
Cancer; 2019 Feb; 125(3):442-452. PubMed ID: 30311655
[TBL] [Abstract][Full Text] [Related]
32. Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study.
Ramchandren R; Domingo-Domènech E; Rueda A; Trněný M; Feldman TA; Lee HJ; Provencio M; Sillaber C; Cohen JB; Savage KJ; Willenbacher W; Ligon AH; Ouyang J; Redd R; Rodig SJ; Shipp MA; Sacchi M; Sumbul A; Armand P; Ansell SM
J Clin Oncol; 2019 Aug; 37(23):1997-2007. PubMed ID: 31112476
[TBL] [Abstract][Full Text] [Related]
33. Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
Gandikota N; Hartridge-Lambert S; Migliacci JC; Yahalom J; Portlock CS; Schöder H
Cancer; 2015 Jun; 121(12):1985-92. PubMed ID: 25739719
[TBL] [Abstract][Full Text] [Related]
34. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract][Full Text] [Related]
35. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Cardiovascular Mortality among 80,042 Older Patients with Bladder Cancer.
Guan T; Su M; Luo Z; Peng W; Zhou R; Lu Z; Feng M; Li W; Teng Y; Jiang Y; Ou C; Chen M
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230496
[TBL] [Abstract][Full Text] [Related]
37. Cause-specific mortality after diagnosis of thyroid cancer: a large population-based study.
Du B; Wang F; Wu L; Wang Z; Zhang D; Huang Z; Gao L; Li Y; Liang C; Li P; Yao R
Endocrine; 2021 Apr; 72(1):179-189. PubMed ID: 32770440
[TBL] [Abstract][Full Text] [Related]
38. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
39. Incidental abnormal ECG findings and long-term cardiovascular morbidity and all-cause mortality: A population based prospective study.
Goldman A; Hod H; Chetrit A; Dankner R
Int J Cardiol; 2019 Nov; 295():36-41. PubMed ID: 31412991
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings.
Gupta GK; Agrawal T; Pilichowska M
BMC Cancer; 2020 Jun; 20(1):535. PubMed ID: 32513132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
